These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9109408)

  • 21. Production, characterization and cytotoxic properties of a diphtheria toxin-ciliary neurotrophic factor fusion protein.
    Negro A; Skaper SD
    Protein Eng; 1995 Feb; 8(2):175-83. PubMed ID: 7630888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and cytotoxic profile of a diphtheria toxin-neurotrophin-4 chimera.
    Negro A; Skaper SD
    J Neurochem; 1997 Feb; 68(2):554-63. PubMed ID: 9003040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin-related interleukin-2 fusion protein.
    Kirkman RL; Bacha P; Barrett LV; Forte S; Murphy JR; Strom TB
    Transplantation; 1989 Feb; 47(2):327-30. PubMed ID: 2645719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicology and pharmacokinetics of DT388IL3, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human interleukin 3 (IL3), in cynomolgus monkeys.
    Cohen KA; Liu TF; Cline JM; Wagner JD; Hall PD; Frankel AE
    Leuk Lymphoma; 2004 Aug; 45(8):1647-56. PubMed ID: 15370220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diphtheria toxin fused to variant human interleukin-3 induces cytotoxicity of blasts from patients with acute myeloid leukemia according to the level of interleukin-3 receptor expression.
    Testa U; Riccioni R; Biffoni M; Diverio D; Lo-Coco F; Foà R; Peschle C; Frankel AE
    Blood; 2005 Oct; 106(7):2527-9. PubMed ID: 15928038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4).
    Cai J; Zheng T; Murphy J; Waters CA; Lin GY; Gill PS
    Invest New Drugs; 1997; 15(4):279-87. PubMed ID: 9547670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
    Murphy JR; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom TB
    Biochem Soc Symp; 1987; 53():9-23. PubMed ID: 2847744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor-induced hepatotoxicity is mediated by Kupffer cells.
    Westcott MM; Abi-Habib RJ; Cohen KA; Willingham MC; Liu S; Bugge TH; Leppla SH; Frankel AE
    Mol Cancer Ther; 2004 Dec; 3(12):1681-9. PubMed ID: 15634662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ontak-like human IL-2 fusion toxin.
    Wang Z; Zheng Q; Zhang H; Bronson RT; Madsen JC; Sachs DH; Huang CA; Wang Z
    J Immunol Methods; 2017 Sep; 448():51-58. PubMed ID: 28551309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diphtheria toxin-based receptor-specific chimaeric toxins as targeted therapies.
    Sweeney EB; Murphy JR
    Essays Biochem; 1995; 30():119-31. PubMed ID: 8822152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting diphtheria toxin to growth factor receptors.
    Murphy JR; vanderSpek JC
    Semin Cancer Biol; 1995 Oct; 6(5):259-67. PubMed ID: 8562903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion toxin. Internal in-frame deletion from Thr387 to His485 results in the formation of a highly potent fusion toxin which is resistant to proteolytic degradation.
    Wen ZL; Tao X; Lakkis F; Kiyokawa T; Murphy JR
    J Biol Chem; 1991 Jul; 266(19):12289-93. PubMed ID: 1648090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
    Bacha P; Williams DP; Waters C; Williams JM; Murphy JR; Strom TB
    J Exp Med; 1988 Feb; 167(2):612-22. PubMed ID: 3126255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterization.
    Potala S; Verma RS
    J Biotechnol; 2010 Jul; 148(2-3):147-55. PubMed ID: 20580754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein.
    Williams DP; Parker K; Bacha P; Bishai W; Borowski M; Genbauffe F; Strom TB; Murphy JR
    Protein Eng; 1987 Dec; 1(6):493-8. PubMed ID: 3334101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma.
    Cheung LS; Fu J; Kumar P; Kumar A; Urbanowski ME; Ihms EA; Parveen S; Bullen CK; Patrick GJ; Harrison R; Murphy JR; Pardoll DM; Bishai WR
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3100-3105. PubMed ID: 30718426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand-induced phosphorylation of the murine interleukin 3 receptor signals its cleavage.
    Mui AL; Kay RJ; Humphries RK; Krystal G
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10812-6. PubMed ID: 1332057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro interleukin-3 binding to leukemia cells predicts cytotoxicity of a diphtheria toxin/IL-3 fusion protein.
    Alexander RL; Kucera GL; Klein B; Frankel AE
    Bioconjug Chem; 2000; 11(4):564-8. PubMed ID: 10898579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DAB(389)IL-2 (denileukin diftitox, ONTAK): a new fusion protein technology.
    Foss FM
    Clin Lymphoma; 2000 Nov; 1 Suppl 1():S27-31. PubMed ID: 11707860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.